CHF fase I BMS
A Randomized, Double-Blinded, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986224 in Healthy Subjects and Chronic HFrEF
- Stadium
- klaar
- Middel
- BMS-986224
- Populatie
- Hartfalen
- Fase
- Ib
- First Patient In
- -
- Last Patient In
- 29 april 2019
- Last Patient Last Visit
- -
Contact Bestuur
